Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Neoplasms 2Tobacco Use Disorder 1Stress Disorders, Post-Traumatic 1Smoking Cessation 1Head and Neck Neoplasms 1Depression 1Anxiety Disorders 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 1251Specimen Handling 867Carboplatin 816Magnetic Resonance Spectroscopy 803Cyclophosphamide 794Cisplatin 715Nivolumab 646Paclitaxel 623Radiotherapy 564Gemcitabine 562Biopsy 529Bevacizumab 468Dexamethasone 433fludarabine 404Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 352Capecitabine 350atezolizumab 341Rituximab 326durvalumab 326Doxorubicin 313Radiosurgery 305Pemetrexed 302Drug Therapy 294Standard of Care 292Ipilimumab 289Etoposide 279Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Amyloid × 1 year × Clear all
NCT05126823 2026-05-05

Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients

Universidad de Córdoba

Phase NA Active not recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT06883097 2025-12-17

QMH

Wake Forest University Health Sciences

Phase NA Recruiting
314 enrolled

Acquired Immunodeficiency Syndrome, Tobacco Use Disorder, Smoking Cessation

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting
125 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04058795 2025-07-30

PTSD Mobile App for Cancer Survivors

Duke University

Phase NA Completed
524 enrolled

Anxiety Disorders, Depression, Neoplasms, Stress Disorders, Post-Traumatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡